Journal articleAm J Manag Care2019
Current treatment landscape and emerging therapies for pancreatic cancer.
- Journal
- Am J Manag Care
- Published
- 1 January 2019
- Citations
- 25
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Pancreatic cancer remains a disease that is difficult to treat due to a typically late presentation, relatively high resistance to chemotherapy, and lack of effective targeted therapies. The standard of care relies on cytotoxic chemotherapy, primarily FOLFIRINOX and gemcitabine-based regimens. … Excerpt only: this text is the publisher’s. Read it in full at the source.